Matthew Brendon Might, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 9 | 2021 | 26 | 2.080 |
Why?
|
Rare Diseases | 5 | 2023 | 553 | 1.520 |
Why?
|
General Practice | 1 | 2023 | 99 | 0.820 |
Why?
|
Nephrology | 1 | 2023 | 266 | 0.680 |
Why?
|
Congenital Disorders of Glycosylation | 4 | 2021 | 43 | 0.580 |
Why?
|
Genetic Diseases, Inborn | 2 | 2017 | 588 | 0.520 |
Why?
|
Computational Biology | 3 | 2020 | 3506 | 0.460 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2021 | 1702 | 0.410 |
Why?
|
Prenatal Diagnosis | 1 | 2016 | 1227 | 0.350 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4182 | 0.310 |
Why?
|
Abnormalities, Multiple | 1 | 2014 | 1405 | 0.280 |
Why?
|
High-Throughput Screening Assays | 2 | 2021 | 953 | 0.230 |
Why?
|
Receptor, trkB | 1 | 2021 | 125 | 0.190 |
Why?
|
RNA Helicases | 1 | 2021 | 142 | 0.190 |
Why?
|
Knowledge | 1 | 2022 | 174 | 0.180 |
Why?
|
Genomics | 3 | 2023 | 5652 | 0.180 |
Why?
|
Metagenomics | 1 | 2023 | 428 | 0.180 |
Why?
|
Knowledge Bases | 1 | 2020 | 85 | 0.180 |
Why?
|
Megakaryocytes | 1 | 2023 | 542 | 0.170 |
Why?
|
Algorithms | 1 | 2020 | 13872 | 0.170 |
Why?
|
Community-Acquired Infections | 1 | 2023 | 463 | 0.170 |
Why?
|
Mutation | 7 | 2021 | 29658 | 0.160 |
Why?
|
Proton Pumps | 1 | 2017 | 30 | 0.150 |
Why?
|
Vocabulary | 1 | 2018 | 167 | 0.150 |
Why?
|
Bacteremia | 1 | 2023 | 957 | 0.140 |
Why?
|
Drug Repositioning | 1 | 2018 | 232 | 0.140 |
Why?
|
Drosophila Proteins | 2 | 2022 | 1697 | 0.130 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1156 | 0.130 |
Why?
|
NF-kappa B | 1 | 2023 | 2502 | 0.120 |
Why?
|
Biomedical Research | 2 | 2020 | 3301 | 0.120 |
Why?
|
Metformin | 1 | 2021 | 827 | 0.120 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 1994 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2020 | 1777 | 0.110 |
Why?
|
Brain Diseases | 1 | 2021 | 1551 | 0.110 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2016 | 483 | 0.110 |
Why?
|
Proton Pump Inhibitors | 1 | 2017 | 519 | 0.100 |
Why?
|
Internet | 2 | 2021 | 3048 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2694 | 0.100 |
Why?
|
Humans | 29 | 2023 | 739398 | 0.100 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 728 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1662 | 0.100 |
Why?
|
Signal Transduction | 1 | 2014 | 23355 | 0.090 |
Why?
|
Drug Discovery | 1 | 2019 | 1056 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2023 | 5305 | 0.090 |
Why?
|
Phenotype | 4 | 2021 | 16301 | 0.090 |
Why?
|
Patient Participation | 2 | 2018 | 1441 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2020 | 5058 | 0.090 |
Why?
|
Cardiology | 1 | 2020 | 1654 | 0.090 |
Why?
|
Language | 1 | 2018 | 1447 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1621 | 0.080 |
Why?
|
Anticonvulsants | 1 | 2018 | 1907 | 0.080 |
Why?
|
Palliative Care | 1 | 2023 | 3461 | 0.080 |
Why?
|
Veterans | 1 | 2021 | 2505 | 0.080 |
Why?
|
Kidney | 1 | 2023 | 7144 | 0.070 |
Why?
|
HEK293 Cells | 3 | 2021 | 4174 | 0.070 |
Why?
|
Software | 2 | 2018 | 4423 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3802 | 0.070 |
Why?
|
Homozygote | 2 | 2021 | 1788 | 0.070 |
Why?
|
Lung | 1 | 2023 | 9782 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 7690 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10208 | 0.060 |
Why?
|
Heterozygote | 2 | 2021 | 2798 | 0.060 |
Why?
|
Interferon Regulatory Factor-2 | 1 | 2022 | 23 | 0.050 |
Why?
|
Epilepsy | 1 | 2018 | 3289 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5702 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9387 | 0.050 |
Why?
|
Wnt1 Protein | 1 | 2022 | 117 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17384 | 0.050 |
Why?
|
Alabama | 1 | 2020 | 97 | 0.050 |
Why?
|
Zebrafish | 2 | 2022 | 2980 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 618 | 0.040 |
Why?
|
Child, Preschool | 2 | 2021 | 40802 | 0.040 |
Why?
|
Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 2017 | 22 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2021 | 604 | 0.040 |
Why?
|
Karyotyping | 1 | 2019 | 1241 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2019 | 797 | 0.040 |
Why?
|
Male | 7 | 2023 | 349022 | 0.040 |
Why?
|
Acetylglucosamine | 1 | 2018 | 191 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1583 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1654 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2018 | 232 | 0.030 |
Why?
|
Oligopeptides | 1 | 2021 | 1179 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15987 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2018 | 624 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10945 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15070 | 0.030 |
Why?
|
Infant | 1 | 2016 | 34923 | 0.030 |
Why?
|
Glycosylation | 1 | 2018 | 1125 | 0.030 |
Why?
|
Data Mining | 1 | 2020 | 536 | 0.030 |
Why?
|
Drosophila | 1 | 2022 | 1478 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1786 | 0.030 |
Why?
|
Glycoproteins | 1 | 2021 | 2259 | 0.030 |
Why?
|
Molecular Structure | 1 | 2017 | 1925 | 0.030 |
Why?
|
Female | 5 | 2021 | 378853 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2102 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2020 | 4743 | 0.030 |
Why?
|
Bacteria | 1 | 2023 | 2106 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2018 | 1141 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2560 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2018 | 1331 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 3146 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 3768 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3441 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2023 | 3672 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2018 | 1445 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2022 | 4555 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40389 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2018 | 1703 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2124 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5959 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 2861 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 5012 | 0.020 |
Why?
|
Animals | 4 | 2022 | 168368 | 0.020 |
Why?
|
Child | 3 | 2022 | 77033 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7788 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11347 | 0.020 |
Why?
|
Information Dissemination | 1 | 2015 | 1106 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5830 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12761 | 0.020 |
Why?
|
Seizures | 1 | 2018 | 2829 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 71974 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9812 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2019 | 19220 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 76631 | 0.010 |
Why?
|
United States | 2 | 2021 | 69573 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8274 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 28901 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6539 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 38942 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18003 | 0.010 |
Why?
|
Adult | 2 | 2023 | 213394 | 0.010 |
Why?
|
Aged | 2 | 2021 | 162698 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 212863 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 62693 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57650 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 85405 | 0.010 |
Why?
|